Literature DB >> 34039761

Inhaled Nitric Oxide Delivery Systems for Mechanically Ventilated and Nonintubated Patients: A Review.

Stefano Gianni1,2, Ryan W Carroll3,2, Robert M Kacmarek4,2, Lorenzo Berra5,2.   

Abstract

Nitric oxide (NO) is a biologically active molecule approved for the treatment of pulmonary hypertension in newborn patients. Commercially available NO delivery systems use pressurized cylinders as the source of NO and a sensor to control the concentrations of NO and nitrogen dioxide (NO2) delivered. Cylinder-based delivery systems are safe and widely used around the world, but they are bulky, expensive, and reliant on a robust supply chain. In the past few years, novel NO generators and delivery systems have been developed to overcome these limitations. Electric NO generators produce NO from ambient air using high-voltage electrical discharge to ionize air, which leads to the formation of NO, NO2, and ozone (O3). A scavenging system is incorporated to reduce the concentration of the toxic byproducts generated in this type of system. NO can also be generated by the reduction of NO2 by ascorbic acid or released from liquid solutions or solid nanoparticles. The development of easy-to-use, safe, and portable NO delivery systems may enable the delivery of NO in the out-patient setting or at home. Furthermore, non-cylinder-based NO generators reduce the cost of NO production and storage and may therefore make NO delivery feasible in low-resource settings. Here we review commercially available systems that can generate and administer inhalable NO.
Copyright © 2021 by Daedalus Enterprises.

Entities:  

Keywords:  inhalation; nitric oxide; nitrogen dioxide; respiratory therapy

Year:  2021        PMID: 34039761     DOI: 10.4187/respcare.08856

Source DB:  PubMed          Journal:  Respir Care        ISSN: 0020-1324            Impact factor:   2.258


  4 in total

Review 1.  Inhaled nitric oxide: role in the pathophysiology of cardio-cerebrovascular and respiratory diseases.

Authors:  Lorenzo Berra; Emanuele Rezoagli; Davide Signori; Aurora Magliocca; Kei Hayashida; Jan A Graw; Rajeev Malhotra; Giacomo Bellani
Journal:  Intensive Care Med Exp       Date:  2022-06-27

Review 2.  Nitric oxide for the prevention and treatment of viral, bacterial, protozoal and fungal infections.

Authors:  Philip M Bath; Christopher M Coleman; Adam L Gordon; Wei Shen Lim; Andrew J Webb
Journal:  F1000Res       Date:  2021-07-05

Review 3.  Therapeutic Effects of Inhaled Nitric Oxide Therapy in COVID-19 Patients.

Authors:  Nikolay O Kamenshchikov; Lorenzo Berra; Ryan W Carroll
Journal:  Biomedicines       Date:  2022-02-03

4.  Inhaled Nitric Oxide for Fibrotic Interstitial Lung Disease: A Step Forward.

Authors:  Yet H Khor; Ayodeji Adegunsoye
Journal:  Ann Am Thorac Soc       Date:  2022-04
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.